You have accessJournal of UrologyImaging/Radiology: Uroradiology III1 Apr 2016MP19-15 RADIATION EXPOSURE OF THE SURGEON: BENEFIT AND PRACTICABILITY OF A LEAD-ACRYL SHIELD FOR URETEROSCOPY Thomas Knoll, Jan Peter Jessen, Heiko Kohns, Roland Steiner, Roland Umbach, and Gunnar Wendt-Nordahl Thomas KnollThomas Knoll More articles by this author , Jan Peter JessenJan Peter Jessen More articles by this author , Heiko KohnsHeiko Kohns More articles by this author , Roland SteinerRoland Steiner More articles by this author , Roland UmbachRoland Umbach More articles by this author , and Gunnar Wendt-NordahlGunnar Wendt-Nordahl More articles by this author View All Author Informationhttps://doi.org/10.1016/j.juro.2016.02.2763AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookTwitterLinked InEmail INTRODUCTION AND OBJECTIVES Patients with urolithiasis are exposed to significant radiation due to imaging for diagnosis, intraoperative management and follow-up. The need for repeated imaging is therefore weighted against potential hazards of radiation. However, radiation protection is as well a serious issue for endourologists. The purpose of this study was to evaluate the potential benefit and practicability of a lead-acryl shield during ureteroscopy (URS). METHODS We performed a prospective evaluation of 30 consecutive rigid and flexible URS for ureteral and renal calculi. All procedures were done on a fluoroscopic working place (over-the-table fluoroscopy source, Primera 360, Storz Medical, Switzerland) under video-endoscopic control. The patients were divided into two groups with or without use of a ceiling-mounted, mobile lead-acryl shield (30x50cm, lead equivalent 0.5 mm, Mavig, Germany) placed at the level of the symphysis, protecting the head and chest of the surgeon. Dose-area product (mGy/m2, DAP) was assessed. The surgeon's radiation exposure was measured with a thermoluminescent dosimeter (TLD) at the forehead and one at the ring finger (as control below the shield). RESULTS Mean age of patients was in 48.1 yrs. in control and 49.5 yrs. in lead group (n.s.). BMI was 26.3 and 28.0 (n. s). OR time was slightly shorter in the control (39.2 vs. 53.9 min., p=0.2) and a consecutively lower DAP of 390.0 vs. 642.7 mGy/m2 (p=0.01). In contrast, the forehead exposure was lower in the acryl-lead group (13.9 vs. 33.7 µSv, p=0.035). There was no difference for the ring dosimeter exposure (p=0.6). The practicability rating was variable, mainly surgeon-specific. While one surgeon felt comfortable with the shield, others felt limited by it. CONCLUSIONS Surgeons should be aware of their high radiation exposure when performing URS. Measures to protect the OR staff are mandatory. Our new concept of using an acryl-lead shield demonstrates a clear reduction in head and chest exposure. However, this device should be optimized for the use in URS to maintain full maneuverability to the surgeon. © 2016FiguresReferencesRelatedDetails Volume 195Issue 4SApril 2016Page: e209-e210 Advertisement Copyright & Permissions© 2016MetricsAuthor Information Thomas Knoll More articles by this author Jan Peter Jessen More articles by this author Heiko Kohns More articles by this author Roland Steiner More articles by this author Roland Umbach More articles by this author Gunnar Wendt-Nordahl More articles by this author Expand All Advertisement Advertisement PDF downloadLoading ...
Read full abstract